Pharma Equity Group A/S (CPH:PEG)
Denmark · Delayed Price · Currency is DKK 0.0776
-0.0024 (-3.00%)
Sep 25, 2026, 4:39 PM CET
Pharma Equity Group Cash Flow Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | -10.45 | -25.38 | -40.61 | -24.35 | -9.44 |
Depreciation & Amortization | 0.29 | 0.31 | 0.24 | 0.22 | 0.54 |
Stock-Based Compensation | - | - | - | - | 0.22 |
Provision & Write-off of Bad Debts | -5.64 | 8.12 | 16.19 | - | - |
Other Operating Activities | 1.08 | -0.46 | 1.32 | -0.29 | -0.37 |
Change in Accounts Receivable | -0.17 | -0.17 | 1.87 | -1.36 | 0.16 |
Change in Accounts Payable | -0.23 | -0.23 | -1.09 | 2.02 | 0.86 |
Change in Other Net Operating Assets | 4.59 | 0.15 | -0.77 | 2.73 | -0.26 |
Operating Cash Flow | -10.52 | -17.66 | -22.86 | -16.62 | -8.3 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Capital Expenditures | - | - | - | -0.07 | - |
Sale of Property, Plant & Equipment | 0.01 | 0.01 | - | - | - |
Investing Cash Flow | 0.01 | 0.01 | - | -0.07 | - |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Short-Term Debt Issued | - | 2.97 | 13.1 | 5.25 | - |
Long-Term Debt Issued | - | - | 11.02 | 8 | - |
Total Debt Issued | 3.98 | 2.97 | 24.11 | 13.25 | - |
Short-Term Debt Repaid | - | -1.19 | -32.32 | -4.33 | - |
Long-Term Debt Repaid | - | -4.92 | -11.87 | -0.2 | -0.28 |
Lease Payments | -0.32 | -0.31 | -0.25 | -0.2 | -0.28 |
Total Debt Repaid | -0.41 | -6.11 | -44.19 | -4.53 | -0.28 |
Net Debt Issued (Repaid) | 3.57 | -3.14 | -20.07 | 8.72 | -0.28 |
Issuance of Common Stock | - | - | 51.15 | 12.19 | - |
Other Financing Activities | 6.27 | 17.06 | -8.21 | -3.85 | - |
Financing Cash Flow | 9.84 | 13.91 | 22.86 | 17.06 | -0.28 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Miscellaneous Cash Flow Adjustments | -0 | - | - | 1.04 | - |
Net Cash Flow | -0.67 | -3.74 | 0 | 1.4 | -8.57 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | -10.52 | -17.66 | -22.86 | -16.7 | -8.3 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 |
Levered Free Cash Flow | 13.23 | -10.26 | -14.7 | -65.07 | - |
Unlevered Free Cash Flow | 15.15 | -8.66 | -11.6 | -64.1 | - |
Free Cash Flow After Leases | -10.84 | -17.97 | -23.11 | -16.9 | -8.57 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash Interest Paid | - | 0.56 | 4.07 | 1.43 | 0.02 |
Cash Income Tax Paid | - | - | -2.23 | -1.86 | -1.48 |
Change in Working Capital | 4.19 | -0.25 | 0.01 | 3.39 | 0.76 |